Rapid Micro Biosystems/$RPID
1D1W1MYTD1Y5YMAX
About Rapid Micro Biosystems
Rapid Micro Biosystems Inc is a life sciences technology company. Its technology uses a sensitive camera and the natural autofluorescence of living cells to identify and quantify microbial growth faster and more accurately than the traditional method, which relies on the human eye. The company develops, manufactures, markets, and sells Growth Direct systems (Systems), proprietary consumables, laboratory information management system (LIMS) connection, and other software and services to address rapid microbial analysis used for quality control in the manufacture of pharmaceuticals, medical devices, and personal care products. Geographically, it generates maximum revenue from the United States, and the rest from Switzerland, Germany, Japan, and all other countries.
- Ticker
- $RPID
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 171
- Headquarters
- Lexington, United States
- Website
- www.rapidmicrobio.com
RPID Metrics
BasicAdvanced
$79M
-
-$1.11
1.48
-
Price and volume
Market cap
$79M
Beta
1.48
52-week high
$4.94
52-week low
$1.52
Average daily volume
217K
Financial strength
Current ratio
2.549
Quick ratio
1.393
Long term debt to equity
124.724
Total debt to equity
132.285
Interest coverage (TTM)
-21.16%
Profitability
EBITDA (TTM)
-47.083
Gross margin (TTM)
5.55%
Net profit margin (TTM)
-145.55%
Operating margin (TTM)
-141.45%
Effective tax rate (TTM)
-0.15%
Revenue per employee (TTM)
$210,000
Management effectiveness
Return on assets (TTM)
-46.40%
Return on equity (TTM)
-141.65%
Valuation
Price to revenue (TTM)
2.054
Price to book
4.42
Price to tangible book (TTM)
4.42
Price to free cash flow (TTM)
-1.789
Free cash flow yield (TTM)
-55.90%
Free cash flow per share (TTM)
-0.878
Growth
Revenue change (TTM)
16.13%
Earnings per share change (TTM)
11.02%
3-year revenue growth (CAGR)
22.47%
3-year earnings per share growth (CAGR)
-7.81%
RPID News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.